Early Clinical Trial Results Back New Drug For Melanoma

Courtesy ScienceDaily  Fri, 04/18/2008 - 07:00

Preliminary but encouraging findings from a Phase 0 human clinical trial of a melanoma drug have been reported. Scientists found an approved drug used to treat Lou Gehrig's disease (ALS), slows the growth of melanoma, the most aggressive form of malignant skin cancer.


 

Related items

Early clinical trial results back new drug for melanoma
Preliminary but encouraging findings from a Phase 0 human clinical trial of a melanoma drug were reported during a plenary session at the annual...

Older Australians At Risk Of Sun-related Skin Cancer Death
A new Western Australian study has revealed the mortality from nonmelanoma skin cancer, commonly considered less dangerous than melanoma, is...

More Genes For Lou Gehrig's Disease Identified
In recent months a spate of mutations have been found in a disease protein called TDP-43 that is implicated in two neurodegenerative disorders:...

More Than Skin Deep: There's No Such Thing As A 'Safe' Suntan,...
There may be no such thing as a 'safe' tan based on ultraviolet radiation, according to a series of papers published in the journal Pigment Cell &...

Scent Of Skin Cancer Discovered
Odors from skin can be used to identify basal cell carcinoma, the most common form of skin cancer, according to new research. The findings may enable...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com